SCI & TECH● LOW2h ago · Oct 9, 2026, 4:10 PM
Glaukos' iDose TR meets primary goal in phase 4 trial
Seeking Alpha Tech · global
Glaukos' iDose TR met its primary goal in a phase 4 trial. This indicates a routine positive development in medical research and pharmaceutical testing.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH1h agoTesla drops 'Full Self-Driving' brand name in Europe after regulator pushbackCNBCSCI & TECH1h agoSpaceX says Starlink will "become a major mobile carrier in the U.S."CBS NewsSCI & TECH1h agoTwo large asteroids found spinning as fast as a fairground rideNew ScientistSCI & TECH2h agoOpenAI defends firing AI safety researchers over "breach of trust"CBS News